Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 20-Hydroxyecdysone SCHEMBL20033388 | 1.00 | MEN1 (0.71) | MEN1KMT2A | |
| 20-Hydroxyecdysone SCHEMBL9481370 | 1.00 | MEN1 (0.71) | MEN1KMT2A | |
| 20-Hydroxyecdysone SCHEMBL8193574 | 1.00 | MEN1 (0.71) | MEN1KMT2A | |
| 20-Hydroxyecdysone SCHEMBL6243068 | 1.00 | MEN1 (0.71) | MEN1KMT2A | |
| 20-Hydroxyecdysone SCHEMBL8193572 | 1.00 | MEN1 (0.71) | MEN1KMT2A | |
| 20-Hydroxyecdysone SCHEMBL990951 | 1.00 | MEN1 (0.71) | MEN1KMT2A | |
| 20-Hydroxyecdysone SCHEMBL22087 | 1.00 | MEN1 (0.71) | MEN1KMT2A | |
| 20-Hydroxyecdysone SCHEMBL8861138 | 1.00 | MEN1 (0.71) | MEN1KMT2A | |
| 20-Hydroxyecdysone SCHEMBL17580332 | 1.00 | MEN1 (0.71) | MEN1KMT2A | |
| 20-Hydroxyecdysone SCHEMBL8861142 | 1.00 | MEN1 (0.71) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7658954-B2 | Synergistic antipyretic formulation | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-02-09 | — | — | US | disclosed |
| US-7429397-B2 | Herbal formulation as memory enhancer in Alzheimer condition | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2008-09-30 | — | — | US | disclosed |
| US-7344739-B2 | Anti-allergic herbal formulation | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2008-03-18 | — | — | US | disclosed |
| US-7247322-B2 | Herbal nutritious chocolate formulation and process for preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (US) | 2007-07-24 | — | — | US | disclosed |
| US-20060141069-A1 | Synergistic antipyretic formulation | Council of Scientific and Industrial Research (an Indian registered body incorporated under the (IN) | 2006-06-29 | — | — | US | disclosed |
| US-20060141066-A1 | Herbal nutritious chocolate formulation and process for preparation thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH | 2006-06-29 | — | — | US | disclosed |
| US-20060141068-A1 | Herbal formulation as memory enhancer in alzheimer condition | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH | 2006-06-29 | — | — | US | disclosed |
| WO-2006067537-A1 | A SYNERGISTIC ANTIPYRETIC FORMULATION | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006067796-A1 | HERBAL FORMULATION AS MEMORY ENHACHER IN ALZHEIMER CONDITION | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006067802-A1 | ANTI-ALLERGIC HERBAL FORMULATION(S) | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-06-29 | — | — | WO | disclosed |
| US-20060141067-A1 | Stimulant and resistant to various pathogens and acts as an immunomodulation as a tablet, injection and as a liquid; extract of Tinospora cardifolia, Piper longum, Albizia lebbeck and Curcunla amada | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH | 2006-06-29 | — | — | US | disclosed |
| US-20050191385-A1 | Natural product derivatives as food supplements and pharmaceuticals | AMATO DANIEL K (US) | 2005-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050191385-A1 | Natural product derivatives as food supplements and pharmaceuticals | NGLY1, FABP6, VIP | MEN1 1503/4885KMT2A 4421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.